Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes - Concepedia

Concepedia

Publication | Closed Access

Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes

40

Citations

26

References

2015

Year

Yoshimasa Aso, Maiko Fukushima, Masaaki Sagara, Teruo Jojima, Toshie Iijima, Kunihiro Suzuki, Atsushi Momobayashi, Kikuo Kasai, Toshihiko Inukai

Diabetes Research and Clinical Practice

Metabolic SyndromeAutoimmune DiseaseDiabetesImmunologyType 2AutoimmunityCd4+ T CellsDiabetes MellitusImmunotherapyMedicineInsulin SignalingDpp-4 Inhibitor

References

	Year	Citations

Page 1

Page 1